Tic Doloureau
4.3 per 100,000
Slight female predominance : 1.74
t0 1
Peak incidence 60-70 y.o.
Unusual before age 40
No racial prediliction
Tic Doloureau
Higher incidence with M.S. &
HTN
Spontaneous remission possible,
BUT unusual
Most patients will have episodic
Classical Criteria
A. Paroxysmal attacks of pain lasting
trigger factors
Classical Criteria
C. Attacks are stereotyped in
Symptomatic Criteria
A. Paroxysmal attacks of pain lasting
trigger factors
Symptomatic Criteria
C. Attacks are stereotyped
Pathophysiology
? Pathophysiology ?
Demyelination of the trigeminal nerve,
Diagnosis
Clinical
Consider in all patients with
Red Flags
Abnormal Neuro exam
Abnormal oral, dental, or ear exam
Age < 40 yrs
Bilateral SXs
Dizziness or vertigo
Red Flags
Hearing loss
Numbness
Pain lasting > 2 minutes
Pain outside of trigeminal distribution
Visual changes
Diagnostic History
Very important
Recurrent, unilateral facial pain
Lasts seconds
May recur 100s of times per day
Pain :
Severe
Sharp
Superficial
Stereotypical
Stabbing
Shock-like
Diagnostic History
1 or more of the nerves divisions
Trigger factors:
Talking
Smiling
Chewing
Teeth brushing
Shaving
Applying make-up
Wind
Physical Exam
Usually a normal exam
Useful for identifying abnormals that
Diagnostic Testing
Generally Not helpful
MRI is the Test of Choice : C Rec
? Trigeminal reflex testing? Unclear
Differential List
Cluster HA Dental Pain
Giant Cell Arteritis
Migraine
Glossopharyngeal
Neuralgia Otitis Media
Intracranial Tumor
Multiple Sclerosis
Sinusitis
TMJ Syndrome
Postherpetic Neuralgia
Paroxysmal
Hemicrania
Treatment
Medical
Surgical
No Behavioral, unless it becomes a
Medical Treatment
Carbamazepine : A Rec
NNT = 2.5 (For trigeminal Neuralgia)
NNH = 3.7 (For all diseases)
Some suggest it as a diagnostic trial
Doses range from 100 to 2,400 mg per
day
Most respond to 200 to 800 mg per day
Immediate release (lasts about 6 hrs.)
Extended release (lasts about 12 hrs.)
Medical Treatment
Carbamazepine Should be the initial
Medical Treatment
Other agents to try : ( Not listed in any
order)
Baclofen : 10 m- 80 mg daily
Dilantin
Lamictal
Neurontin
Topamax
Klonopin
Orap
Depakene
Medical Treatment
A recent Cochrane review said there
Follow-up
Achieve balance between pain and
Surgical Treatment
After failure of Pharm agents
Unusual
Recurrences occur for many
Both percutaneous & open techniques
Glycerol injection Ballon Compression
Radio Rhizotomy Gamma knife
Partial RhizotomyMicrovascular
decompression
Summary
2 Types of trigeminal neuralgia
A clinical DX
Everyone gets a head & face
MRI
Carbamazepine is the
treatment of choice.
References
Kraft, RM. Trigeminal Neuralgia.
AFP. 2008;77:1291-1296.
Cochrane Collaboration
Haanpaa M, et al. Neuropathic
Facial Pain. Suppl Clin
Neurophysiol. 2006;58:153-170.
References
Cruccu G, et al. Diagnosis of